Exjade

Medicinal product

(Invented) name

Exjade

Active substance (s)

Deferaziroksas

Strength

500 mg

Pharmaceutical form

disperguojamosios tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

V03AC03, Deferasirox

Marketing authorisation holder

Novartis Europharm Ltd., Airija

Date of authorisation

2006-08-28

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Dispersible tablet	1 vnt.
Deferaziroksas	500 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
25489	28095	1028095	lizdinė plokštelė	N28		Receptinis	EU/1/06/356/005	Netiekiama	-	-	No	-	-
25490	28096	1028096	lizdinė plokštelė	N84		Receptinis	EU/1/06/356/006	Netiekiama	-	-	No	-	-
42813	56581	1056581	lizdinė plokštelė	N252		Receptinis	EU/1/06/356/009	Netiekiama	-	-	No	-	-
62261	76652	1076652	lizdinė plokštelė	N294 (3x98) (sudėtinė)		Receptinis	EU/1/06/356/010	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-01-24	Išregistruotas
2006-08-28	Registruotas